A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 77
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NLX
Long Form : naloxone
No. Year Title Co-occurring Abbreviation
2020 Silver nanoparticles (Ag-NPs) in the central amygdala protect the rat conditioned by morphine from withdrawal attack due to naloxone via high-level nitric oxide. CeA, CPP, NO, s.c
2020 The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys. i.n, IM, PET, RO
2019 A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice. E/S
2019 Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review. BPN, MMT, OAT, OUD, RCTs
2018 Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice. IFN-gamma, MPL, rPvTRAP, TRAP
2017 Antiallodynic Activity of Ceftriaxone and Clavulanic Acid in Acute Administration is Associated with Serum TNF-alpha Modulation and Activation of Dopaminergic and Opioidergic Systems. CFX, CLAV, GaP, HAL, NP
2017 Macrophage cell-derived exosomes/staphylococcal enterotoxin B against fibrosarcoma tumor. EXO, EXO, Exos, PRP, SEB
2017 Naloxone effects on extinction of ethanol- and cocaine-induced conditioned place preference in mice. CPP
2016 Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception. i.n, IM, PET
10  2016 Potentiation of human papilloma vaccine candidate using naloxone/alum mixture as an adjuvant: increasing immunogenicity of HPV-16E7d vaccine. HPVs
11  2015 Administration of naloxone in combination with recombinant Plasmodium vivax AMA-1 in BALB/c mice induces mixed Th1/Th2 immune responses. rPvAMA-1
12  2015 Antinociceptive and anti-inflammatory effects of myricetin 3-O-beta-galactoside isolated from Davilla elliptica: involvement of the nitrergic system. AM, D-Arg, iNOS, L-Arg, Mi, NO, NOS, WT
13  2015 Mechanisms of morphine-venlafaxine interactions in diabetic neuropathic pain model. DNPM, PCA, VFX, YOH
14  2014 Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone. AEs, BUP, DCV, GMR, HCV, MET, PK
15  2014 Hollow fiber liquid-phase microextraction combined with ultra-high performance liquid chromatography-tandem mass spectrometry for the simultaneous determination of naloxone, buprenorphine and norbuprenorphine in human plasma. BP, ESI, HF-LPME, LOD, LOQ, MRM, NBP, PVDF, rpm, RSD
16  2014 Nicotine effects and the endogenous opioid system. HPA, nAChR, NIC
17  2014 Respiratory effects of buprenorphine/naloxone alone and in combination with diazepam in naive and tolerant rats. BUP, DZP, VE
18  2014 Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation. beta-END, CFA, LPS, TLR
19  2014 Visceral analgesic effect of 5-HT(4) receptor agonist in rats involves the rostroventral medulla (RVM). beta-FNA, CRD, i.c.v, i.p, i.t, LS, PNA, RVM, TEG, TNBS, VMR
20  2014 [Development of physical dependence on nicotine and endogenous opioid system--participation of alpha7 nicotinic acetylcholine receptor]. HPA, nAChR, NIC
21  2013 Induction of protective immunity against brucellosis in mice by vaccination with a combination of naloxone, alum, and heat-killed Brucella melitensis 16 M. IFN, IL
22  2013 Long-term antinociception by electroacupuncture is mediated via peripheral opioid receptors in free-moving rats with inflammatory hyperalgesia. AA, CFA, EA, NTI
23  2013 Role of the endogenous opioid system in modulation of urinary bladder activity by spinal nerve stimulation. SN, Tmot
24  2012 Electroacupuncture alleviates stress-induced visceral hypersensitivity through an opioid system in rats. AWR, EA, EMG, HIS, m-NLX, NS
25  2011 Development and validation of a sensitive LC/MS/MS method for the simultaneous determination of naloxone and its metabolites in mouse plasma. MRM, NLG, NLL, RE, RSD
26  2011 Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection. ERL, S. typhimurium, Th1
27  2011 Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation. HPA, MEC, MLA, nAChRs, SCS
28  2010 Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine. HKLM, PBS, Th1
29  2010 micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. MOR, VTA
30  2009 A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. gD1, HSV-1, Th
31  2009 Exploring molecular mechanisms of ligand recognition by opioid receptors with metadynamics. DOR, GPCRs
32  2009 Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine. FLNA, MOR, NTX
33  2009 [Pharmacokinetics of 6beta-naltrexol after single and multiple intramuscular injections in Beagle dogs]. 6beta-NOL, HPLC
34  2007 Naloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB/c mice. DTH, HSV-1, IFN-gamma
35  2006 The effect of post-burn local hyperthermia on the reducing burn injury: the possible role of opioids. ---
36  2005 A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. BD
37  2005 Inhibitory control of the acute mu-withdrawal response by indirectly activated adenosine A1 and kappa-opioid systems in the Guinea-pig ileum; reversal by cholecystokinin. BNI, CPT, GPI
38  2005 Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies. i.v, LDV, SA, TEWL
39  2004 Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysis. HPLC, NLT
40  2004 RP-HPLC method and its validation for the determination of naloxone from a novel transdermal formulation. ---
41  2002 Effects of naloxone and post-tetanic stimulation on isolated guinea-pig ileum followed by long exposure to morphine and bestatin. ---
42  2001 Adrenalectomy-induced potentiation of morphine action in guinea-pig ileum: possible decrease in the release of endogenous opioids from opioidergic neurones. MPLM
43  2000 Characteristics of post-tetanic contraction induced by naloxone in guinea pig ileum. ---
44  2000 Involvement of the opioid system in the development and expression of sensitization to the locomotor-activating effect of ethanol. ---
45  1999 Antagonistic effects of naloxone and naloxonazine on sufentanil-induced antinociception and respiratory depression in rats. i.t, i.v, NLZ, s.c, SUF
46  1999 Facilitatory and inhibitory effects of beta-endorphin on lordosis in female rats: relation to time of administration. beta-EP, EB, i.c.v, PROG, sc
47  1998 GM1 ganglioside-induced modulation of opioid receptor-mediated functions. DRG
48  1998 Neuromodulators and hypoxic hypothermia in the rat. Ta, THEO
49  1997 Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. i.p, NTX
50  1996 Opioid peptide participates in post-tetanic twitch inhibition in guinea pig isolated ileum. ---
51  1996 Utilization of a novel model of food reinforced behavior involving neuropeptide Y, insulin, 2-deoxy-d-glucose and naloxone. 2-DG, NPY
52  1995 Naloxone and initial estrogen action to induce lordosis in ovariectomized rats: the effect of a cut between the septum and preoptic area. EB, i.t.v, LQ, PROG, s.c
53  1995 Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. ---
54  1995 Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. APD, DRG, NTX
55  1994 Participation of opioid receptor types on post-tetanic twitch inhibition in isolated guinea-pig ileal longitudinal muscle. beta-FNA, MPLM, nor-BNI
56  1994 Receptor selectivity of icv morphine in the rat cold water tail-flick test. CTAP, nor-BNI, NTI
57  1993 Acute opioid dependence in the cardiovascular system of the spinal rat. ---
58  1993 Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. ---
59  1993 Effect of vasoactive intestinal peptide and naloxone combination on urinary N-acetyl-beta-D-glucosaminidase level and kidney histology of rats exposed to severe hemorrhage. NAG, VIP
60  1993 Respiratory muscle acidosis stimulates endogenous opioids during inspiratory loading. DCA, EMGeo, IRL
61  1992 Dichloroacetate blocks endogenous opioid effects during inspiratory flow-resistive loading. DCA, EMGdi, IRL
62  1992 The effect of vasoactive intestinal peptide (VIP) and naloxone combination on survival rates in rats exposed to severe hemorrhage. VIP
63  1991 [Relationship between central beta-endorphins and serotonin systems in mechanism of hypoxic ventilatory regulation]. beta-EP, OMF, VE
64  1990 Endogenous opioid effects on abdominal muscle activity during inspiratory loading. EMGeo, IRL, VT
65  1990 Naloxone produces protracted tolerance in mice treated with a single dose of morphine. MS
66  1990 Pharmacological studies of lappaconitine. Analgesia produced by intracerebroventricular, intracisternal and intrathecal injections. i.c.v, i.cist, i.t, LA, MOR
67  1989 Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. i.c.v, nor-BNI, s.c
68  1989 Naloxone alters the early response to an inspiratory flow-resistive load. SAL, VT
69  1989 Pharmacological studies of lappaconitine. Occurrence of analgesic effect without opioid receptor. LA
70  1988 Changes of monoamine and TRH contents in naloxone induced inhibited development of rat cerebrum and cerebellum. NLX-rats, TRH
71  1987 Endogenous opioids modulate fetal rabbit lung maturation. P-V
72  1987 Naloxone blocks the interferon-alpha induced changes in hypothalamic neuronal activity. IFN-alpha, PO/AH, VMH
73  1986 Naloxone-induced luteinizing hormone secretion in normal, precocious, and delayed puberty. ---
74  1986 The antagonistic effects of naloxone on cycloheximide and anisomycin-induced amnesia. CXM
75  1985 A drug discrimination analysis of ethanol-induced behavioral excitation and sedation: the role of endogenous opiate pathways. EtOH, EX, sed
76  1982 Naloxone attenuates the anxiolytic action of diazepam in man. DZM
77  1981 Effect of naloxone on ventilation in newborn rabbits. VE